Old Web
English
Sign In
Acemap
>
authorDetail
>
Joe Budman
Joe Budman
Angioedema
Pharmacology
Neprilysin
Omapatrilat
Angiotensin II receptor type 1
2
Papers
54
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery of TD-0212, an Orally Active Dual Pharmacology AT1 Antagonist and Neprilysin Inhibitor (ARNI)
2019
ACS Medicinal Chemistry Letters
R. Murray McKinnell
Paul R. Fatheree
Seok-ki Choi
Roland Gendron
Keith Jendza
Brooke Olson Blair
Joe Budman
Craig M. Hill
Laxminarayan G Hegde
Cécile Yu
Donavon McConn
Sharath S. Hegde
Daniel Marquess
Uwe Klein
Show All
Source
Cite
Save
Citations (5)
Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
2011
Journal of Cardiovascular Pharmacology
Laxminarayan G Hegde
Cécile Yu
Travis Renner
Harold Thibodeaux
Scott Armstrong
Timothy Park
Madhavi Cheruvu
Rachael Olsufka
Erik R Sandvik
Cassie E Lane
Joe Budman
Craig M Hill
Uwe Klein
Sharath S. Hegde
Show All
Source
Cite
Save
Citations (49)
1